The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy

Tunger, A; Sommer, U; Wehner, R; Kubasch, AS; Grimm, MO; Bachmann, MP; Platzbecker, U; Bornhauser, M; Baretton, G; Schmitz, M

Schmitz, M (reprint author), Tech Univ Dresden, Natl Ctr Tumor Dis NCT, Univ Hosp Carl Gustav Carus, Fetscherstr 74, D-01307 Dresden, Germany.; Schmitz, M (reprint author), Tech Univ Dresden, Inst Immunol, Med Fac Carl Gustav Carus, Fetscherstr 74, D-0130

JOURNAL OF CLINICAL MEDICINE, 2019; 8 (10):

Abstract

The administration of antibodies blocking the immune checkpoint molecules programmed cell death protein 1 (PD-1) or programmed cell death 1 ligand 1 (......

Full Text Link